Key result
Midwall septal fibrosis in DCM is linked to ~10% lower regional myocardial blood flow.
Why the study?
Midwall septal fibrosis in DCM is associated with adverse clinical outcomes, but the underlying pathophysiological mechanisms remain incompletely understood.
Does midwall septal fibrosis in dilated cardiomyopathy associate with distinct myocardial microstructural and microvascular abnormalities on CMR?
Observational
No
Does midwall septal fibrosis in dilated cardiomyopathy associate with distinct myocardial microstructural and microvascular abnormalities on CMR?
Midwall septal fibrosis in dilated cardiomyopathy is associated with microstructural remodeling and impaired myocardial perfusion, providing mechanistic insight into its adverse prognostic associations.
BACKGROUND: The presence of midwall septal fibrosis (MSF) in dilated cardiomyopathy (DCM) has been shown to be associated with adverse clinical outcomes but the underlying pathophysiological mechanisms are incompletely understood. We investigated whether MSF associates with a distinct pattern of myocardial microstructural and microvascular abnormalities using advanced cardiovascular magnetic resonance (CMR). METHODS: This was a prospective, multi-referral, single center study comparing the hearts of patients with a current or prior diagnosis of DCM with and without MSF ("MSF+" / "MSF-"), to a control cohort of a similar age and sex distribution. All underwent single-magnet 3 Tesla CMR including cardiac diffusion tensor imaging (cDTI), quantitative rest perfusion and multiparametric tissue characterization. Prespecified analyses compared DCM with controls, and MSF+ with MSF-; secondary analyses included regional septal and within-subject segmental comparisons. RESULTS: /s, p=0.006) and decreased rMBF (0.64 vs 0.71ml/g/min, p=0.013) compared to MSF-. Septal analyses demonstrated increased MD, decreased E2A, decreased FA, and reduced rMBF in DCM. Within-patient comparisons showed decreased perfusion in fibrotic segments compared with non-fibrotic myocardium. In exploratory analyses, decreased rMBF was associated with greater ventricular ectopic burden. CONCLUSION: Midwall septal fibrosis in DCM identifies a distinct myocardial phenotype characterized by microstructural remodeling and impaired myocardial perfusion, with regional and segmental specificity. These findings provide mechanistic insight into the adverse prognostic associations of MSF and highlight a potential imaging-guided pathway for risk stratification and therapies.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2026) conducted an observational in Dilated cardiomyopathy. Midwall septal fibrosis (MSF) vs. DCM without MSF (MSF-) and healthy controls was evaluated on Regional myocardial blood flow (rMBF) (p=0.013). Midwall septal fibrosis in dilated cardiomyopathy was associated with decreased regional myocardial blood flow (0.64 vs 0.71 ml/g/min, p=0.013) compared to patients without fibrosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: